Item response theory and health-related quality of life in cancer

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 3, Issue 6, 2003, Pages 783-791

  Gershon, Richard ^a   Cella, David ^a,b   Dineen, Kelly ^a   Rosenblom, Sarah ^a   Peterman, Amy ^a,b   Lai, Jin Shei ^a,b  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Assessment; Cancer computerized adaptive testing; Health related quality of life; Item bank; Item response theory; Quality of life

Indexed keywords

BRAIN TUMOR; BREAST CANCER; CANCER PAIN; CANCER PATIENT; COGNITION; DAILY LIFE ACTIVITY; EMOTIONAL STRESS; EXHAUSTION; FUNCTIONAL ASSESSMENT; HEALTH CARE QUALITY; HUMAN; OUTCOMES RESEARCH; PATIENT CARE; PHYSICAL CAPACITY; PROSTATE CANCER; QUALITY OF LIFE; RATING SCALE; REVIEW; SOCIAL ASPECT; SOCIAL SUPPORT; WELLBEING; WORLD HEALTH ORGANIZATION;

EID: 0348219023     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.3.6.783     Document Type: Review

References (62)

1. Bode R, Cella D, Lai J-S, Heinemann AW. Developing an initial physical function Item Bank from existing sources. J. Applied Meas. 4, 124-136 (2003).
2. Bode RK, Lai JS, Cella D, Heinemann AW. Issues in the development of an item bank. Arch. Phys. Med. Rehab. 84, S52-S60 (2003).
3. Cella D, Chang CH. A discussion of item response theory and its applications in health status assessment. Med. Care 38, II66-II72 (2000).
4. Lai JS, Cella D, Dineen K, Bode RK, VonRoenn J, Gershon R. Equiprecise measurement of cancer fatigue: An item bank for clinical practice. (In Press) (2003).
5. Hays R, Morales L, Reise S. Item response theory and health outcomes measurements in the 21st Century. Med. Care 38, II28-II42 (2000).
6. McHorney CA, Cohen AS. Equating health status measures with item response theory: illustrations with functional status items. Med. Care 38, 1143-1159 (2000).
7. Ware JE, Bjorner JB, Kosinski M. Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales. Med. Care 38, 473-483 (2000).
8. World Health Organization. Constitution of the World Health Organization. World Health Organization, Geneva, Switzerland. (1946).
9. Heffernan N, Cella D, Webster K et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J. Clin. Oncol. 20, 2229-2239 (2002).
10. Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy-Spiritual Well-being Scale (FACIT-Sp). Ann. Behav. Med. 24, 49-58 (2002).
11. Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94, 528-538 (2002).
12. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch. Phy. Med. Rehab. 83, S10-S17 (2002).
13. Haley SM, McHorney CA, Ware JE, Jr. Evaluation of the MOS SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch item scale. J. Clin. Epidemiol. 47, 671-684 (1994).
14. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273, 59-65 (1995).
15. Kurtz ME, Kurtz JC, Stommel M, Given C, Given B. Physical functioning and depression among older persons with cancer. Cancer Pract. 9, 11-18 (2001).
16. Given B, Given C, Azzouz F, Stommel M. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nursing Res. 50, 222-232 (2001).
17. Fairey AS, Courneya KS, Field CJ, Mackey JR. Physical exercise and immune system functionin cancer survivors: a comprehensive review and future directions. Cancer 94, 539-551 (2002).
18. Courneya KS. Exercise interventions during cancer treatment: biopsychosocial outcomes. Exerc. Sport Sci. Rev. 29, 60-64 (2001).
19. North American Nursing Diagnosis Association. Nursing diagnoses: Definition and Classification, 1997-1998. McGraw-Hill, PA, USA (1996).
20. Cella D, Paul D, Yount S et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Invest. 21(4), 526-535 (2003).
21. American Society of Clinical Oncology. ASCO Curriculum Series: Optimizing Cancer Care - The Importance of Symptom Management. Kendall/Hunt Publishing, IA, USA (2001).
22. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. J. Am. Med. Assoc. 263, 3029-3034 (1990).
23. National Institutes of Health. State-of-the-Science Conference Statement. Symptom Management in Cancer: Pain, Depression and Fatigue. (2002).
24. McDonnell F, Sloan JW, Hamann S. Advances in cancer pain management. Curr. Oncol. Rep. 2, 351-357 (2000).
25. Virik K, Glare P. Pain management in palliative care. Aus. Fam. Phys. 29, 1027-1033 (2000).
26. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann K, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 93, 247-257 (2001).
27. Oncology Nursing Society. Cancer pain management. Oncology Nursing Forum 28, 439-440 (2001).
28. Stjernsward J, Teoh N. Current status of the Global Cancer Control Program of the World Health Organization. J. Pain Symptom Manage. 8, 340-347 (1993).
29. Syrjala K, Abrams J. Cancer pain. In: Psychosocial Factors in Pain: Critical Perspectives. Gatchel RJ, Turk DC (Eds). The Gildford Press, NY, USA, 301-314 (1999).
30. Cleeland CS, Mendoza TR, Wang XS et al. Assessing sypmtom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer 89, 1634-1646 (2000).
31. Zabora JR, Brintzenhofeszoc KM, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 10, 19-27 (2001).
32. Chang VT, Hwang SS, Feuerman M, Kasimis BS. Symptom and quality of life survey of medical oncology patients at a veterans affairs medical center: a role for symptom assessment. Cancer 88, 1175-1183 (2000).
33. Litwin MS, Hays R, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability and validity of health-related quality of life measure. Med. Care 26, 1002-1012 (1998).
34. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations and relation to quality of life. J. Clin. Oncol. 20, 3137-3148 (2002).
35. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of nonsmall-cell lung cancer. J. Clin. Oncol. 20, 2920-2929 (2002).
36. Antoni MH, Lehman JM, Kilbourn KM et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology 20, 20-32 (2001).
37. Stanton AL, Danoff-Burg S, Sworowski LA et al. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J. Clin. Oncol. 20, 4160-4168 (2002).
38. Ahles TA, Saykin AJ, Furstenberg CT et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Psychosomatics 37, 137-143 (2002).
39. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van der Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 95, 183-192 (2002).
40. Chapman SL, Byas-Smith MG, Reed BA. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin. J. Pain 18, S83-S90 (2002).
41. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 18, 2695-2701 (2000).
42. Wagner L, Sweet J, Cella D, Doninger N. chemotherapy-related congnitive deficits: a qualitative examination of providers and patients. Ann. Behav. Med. 25, S056 (2003).
43. George LK, Ellison CG, Larson DB. Exploring the relationships between religious involvement and health. Psychol. Inquiry 13, 190-200 (2002).
44. Thoresen CE, Harris AH, Oman D. Spirituality, religion and health: evidence, issues and concerns. In: Faith and Health: Psychological Perspectives. Plante TG, Sherman AC (Eds). Guilford Press, NY, USA. 15-52 (2001).
45. Brady MJ, Peterman AH, Fitchett G, Mo M, Cella D. A case for including spirituality in quality of life measurement in oncology. Psychooncology 8, 417-428 (1999).
46. Talcott JA, Rieker PP, Clark JA et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J. Clin. Oncol. 16, 275-283 (1998).
47. Hahn EA, Cella D. Health outcomes assessment in vulnerable populations: measurement challenges and recommendations. Arch Phys. Med. Rehab. 84, S35-S42 (2003).
48. Soni MK, Cella D. Quality of life and symptom measures in oncology: an overview. Am. J. Man. Care 8, S560-S573 (2002).
49. Hahn EA, Glendenning GA, Sorensen M et al. Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon- α plus low-dose Ara-C: results form the IRIS Study. J. Clin. Oncol. 21, 2138-2146 (2003).
50. Littlewood TJ, Bajetta E, Nortier J et al. Effects of epoetin α on hematologic parameters and quality of life in cancer patients receiving nanplatinum chemotherapy: results of a randomized, double-blind, placebo-controlted trial. J. Clin. Oncol. 19, 2865-2874 (2000).
51. Fayers P, Hand DJ. Causal variables, indicator variables and measurement scales: an example from quality of life. J. Royal Stat. Soc. 165, 1-21 (2002).
52. Cella D, Chang C-H, Heinemann AW. Item response theory (IRT): applications in quality of life measurement, analysis and interpretation. In: Statistical Methods for Quality of Life Studies: Design, Measurements and Analysis. Mesbah M, Cole B, Lee M-L T (Eds). Kluwer Academic Publishers MA, USA, 169-186 (2002).
53. Gershon R. Computerized adaptive testing J. App. Measurement (2003) (In Press).
54. Andrich D. A rating formulation for ordered response categories. Psychometrika 31, 84-98 (1978).
55. Bock RD. Estimating item parameters and laten ability when responses are scored in two or more nomial categories. Psychometrika 37, 29-51 (1972).
56. Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum. 42, 1797-1808 (1999).
57. Detmar SB, Muller M, Schornagel JH, Wever LD, Aaronson N. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. J. Am. Med. Assoc. 285, 1351-1357 (2002).
58. Velikova G, Brown J, Booth L et al. A randomized study of quality of life measurements in oncology practice - effects on patient well-being and process of care. Proceed. Am. Soc. Clin. Oncol. 22, 728 (2003).
59. Jacobsen PB, Davis K, Cella D. Assessing quality of life in research and clinical practice. Oncology 16, 133-139 (2002).
60. Davis K, Cella D. Assessing quality of life in oncology clinical practice: a review of barriers and critical success factors. JCOM 9, 327-332 (2002).
61. Velikova G, Brown J, Smith A, Selby P. Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br. J. Cancer 86, 51-59 (2002).
62. Buxton J, White M, Osoba D. Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health related quality of life. Qual. Life Res. 7, 513-519 (1998).